Early Urinary Metabolomics in Patent Ductus Arteriosus Anticipates the Fate: Preliminary Data
Introduction: In premature neonates, the persistence of hemodynamically significant ductus arteriosus (hsPDA) can be associated with short- and long-term consequences, impairing their outcome. The correct strategy of management for such condition is under debate, especially regarding contraindicatio...
保存先:
主要な著者: | Flaminia Bardanzellu (著者), Cristina Piras (著者), Alessandra Atzei (著者), Paola Neroni (著者), Vassilios Fanos (著者) |
---|---|
フォーマット: | 図書 |
出版事項: |
Frontiers Media S.A.,
2020-12-01T00:00:00Z.
|
主題: | |
オンライン・アクセス: | Connect to this object online. |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
類似資料
-
How could metabolomics change pediatric health?
著者:: Flaminia Bardanzellu, 等
出版事項: (2020) -
Percutaneous closure of patent ductus arteriosus with the Nit-Occlud® patent ductus arteriosus device in 268 consecutive cases
著者:: Andrii V Maksymenko, 等
出版事項: (2019) -
Ibuprofen and paracetamol for patent ductus arteriosus
著者:: Carlo Dani
出版事項: (2014) -
Patent Ductus Arteriosus in Preterm Infants
著者:: Jia-Yuh Chen
出版事項: (2012) -
Large patent ductus arteriosus: To close or not to close
著者:: Jaganmohan Tharakan, 等
出版事項: (2012)